Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

11.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.7K
Blood Typing01:10

Blood Typing

1.7K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
1.7K
The ABO Blood Group01:12

The ABO Blood Group

2.5K
The ABO blood group system is a critical element of transfusion medicine, essential for determining blood compatibility in transfusions and organ transplants. It is based on specific antigens, or agglutinogens, present on the surface of red blood cells (RBCs) and corresponding antibodies, or agglutinins, in the blood plasma.
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
2.5K
Rh Blood Group01:19

Rh Blood Group

2.1K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.1K
Transcytosis of IgG01:15

Transcytosis of IgG

3.2K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.2K
Blood Transfusion01:15

Blood Transfusion

931
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
931

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Women as Recipients of Recognition Awards from Medical Societies in the United States: A Systematic Review and Meta-Analysis.

Journal of women's health (2002)·2026
Same author

Andes virus, hantavirus infections, and the unresolved question of transfusion transmission.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same author

The Novel C-Terminal Cystine Knot (Exon 52) VWF p.Cys2771Phe Variant Produces a Type 2A von Willebrand Factor Multimer Pattern with an Apparent Dimerization Defect.

Seminars in thrombosis and hemostasis·2026
Same author

Vitamin K Deficiency Bleeding After Refusal: A Sentinel Event in a Misinformation Era.

Pediatrics·2026
Same author

Transfusion-related alpha-gal syndrome: Two new cases expanding the demographic and geographic spectrum, and evidence of a diagnostic gap in allergic transfusion reaction evaluation.

Transfusion·2026
Same author

Directed donations for unvaccinated blood: A departure from evidence-based medicine associated with clinical harm, resource waste, and oversight gaps in a two-year single-center series.

Transfusion·2026
Same journal

Comparison of patient, hospitalization and center characteristics from the EMMY centers, IFM centers, and all multiple myeloma centers in France.

Clinical hematology international·2026
Same journal

Allogeneic hematopoietic stem cell transplantation for VEXAS syndrome: A review and a case report.

Clinical hematology international·2026
Same journal

Is Pseudo-progression post-CAR T therapy real?

Clinical hematology international·2026
Same journal

Bladder mass following bone marrow transplant for sickle cell disease: A diagnostic dilemma.

Clinical hematology international·2026
Same journal

Guidelines and consensus for minimal residual disease-adapted therapy in multiple myeloma from the Pan-Pacific multiple myeloma working group.

Clinical hematology international·2026
Same journal

Should monitoring guidelines and decision to treat for I⁠gM MGUS be different when caring for Jehovah's Witness patients?

Clinical hematology international·2026
See all related articles

Related Experiment Video

Updated: Oct 18, 2025

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.8K

Cold Agglutinin Disease.

Amy P Gabbard1, Garrett S Booth1

  • 1Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

Clinical Hematology International
|October 1, 2021
PubMed
Summary
This summary is machine-generated.

Cold agglutinin disease (CAD) is a rare autoimmune anemia. Diagnosis involves specific lab tests, and treatments like rituximab show promise, unlike ineffective corticosteroids.

Keywords:
Hemolytic anemiacold agglutinin diseasecold agglutinin disease diagnosiscold agglutinin disease therapycold agglutininscold autoimmune hemolytic anemia

More Related Videos

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

2.0K
Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

15.6K

Related Experiment Videos

Last Updated: Oct 18, 2025

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.8K
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

2.0K
Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

15.6K

Area of Science:

  • Hematology
  • Immunology

Background:

  • Cold agglutinin disease (CAD) is a rare autoimmune hemolytic anemia (AIHA).
  • It presents in elderly patients with chronic anemia, potentially with cold-induced extremity symptoms.
  • CAD involves complement-mediated intravascular and extravascular hemolysis.

Purpose of the Study:

  • To outline diagnostic criteria for CAD.
  • To differentiate CAD from warm AIHA.
  • To review current and emerging therapeutic strategies for CAD.

Main Methods:

  • Review of laboratory testing for CAD diagnosis, including the direct antiglobulin test (DAT) and cold agglutinin titer.
  • Comparison of CAD treatment efficacy with warm AIHA therapy.
  • Evaluation of response rates for rituximab, rituximab/fludarabine combination, and novel anti-complement drugs.

Main Results:

  • Nearly all CAD cases are positive for C3d DAT; a negative test suggests warm AIHA.
  • Ninety percent of cold agglutinins are IgM class with titers ≥1:64 at 4°C.
  • Corticosteroids are ineffective for CAD. Rituximab monotherapy benefits 45-60%; combination therapy with fludarabine is effective in up to 76%.

Conclusions:

  • Accurate diagnosis of CAD is crucial as treatments differ from warm AIHA.
  • Rituximab-based therapies offer significant patient benefit.
  • Emerging anti-complement drugs show potential for CAD management.